These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 38157199)
21. Comparison of Botulinum Toxin Injections and Type 2 Thyroplasty for Adductor Spasmodic Dysphonia. Sanuki T; Takemoto N Laryngoscope; 2023 Dec; 133(12):3443-3448. PubMed ID: 37278482 [TBL] [Abstract][Full Text] [Related]
22. Relationship of laryngeal botulinum toxin dosage to patient age, vitality, and socioeconomic issues. Young DL; Halstead LA J Voice; 2014 Sep; 28(5):614-7. PubMed ID: 24954039 [TBL] [Abstract][Full Text] [Related]
23. Quantitative laryngeal electromyography parameters may correlate with improved outcomes following botulinum toxin injection for spasmodic dysphonia. Dwyer CD; Leclerc AA; Nandedkar SD; Young VN; Rosen CA Muscle Nerve; 2021 Apr; 63(4):525-530. PubMed ID: 33382480 [TBL] [Abstract][Full Text] [Related]
24. Treatment efficacy of electromyography versus fiberscopy-guided botulinum toxin injection in adductor spasmodic dysphonia patients: a prospective comparative study. Kim JW; Park JH; Park KN; Lee SW ScientificWorldJournal; 2014; 2014():327928. PubMed ID: 25383369 [TBL] [Abstract][Full Text] [Related]
25. Botulinum Toxin Therapy for Spasmodic Dysphonia in Japan: The History and an Update. Hyodo M; Hirose K; Nagao A; Nakahira M; Kobayashi T Toxins (Basel); 2022 Jul; 14(7):. PubMed ID: 35878189 [TBL] [Abstract][Full Text] [Related]
27. Factors Associated with Failure of Botulinum Toxin Injection in Adductor Spasmodic Dysphonia. Zhao K; Guillaud M; Hu A Ann Otol Rhinol Laryngol; 2020 Oct; 129(10):996-1002. PubMed ID: 32468829 [TBL] [Abstract][Full Text] [Related]
28. Quality of Life After Botulinum Toxin Injection in Patients With Adductor Spasmodic Dysphonia; a Systematic Review and Meta-analysis. Faham M; Ahmadi A; Silverman E; Harouni GG; Dabirmoghaddam P J Voice; 2021 Mar; 35(2):271-283. PubMed ID: 31477348 [TBL] [Abstract][Full Text] [Related]
29. Spasmodic dysphonia and botulinum toxin: experience from the largest treatment series. Blitzer A Eur J Neurol; 2010 Jul; 17 Suppl 1():28-30. PubMed ID: 20590805 [TBL] [Abstract][Full Text] [Related]
30. Laryngeal Botulinum Toxin Injection: Can It Be a Cause of Obstructive Sleep Apnea as an Adverse Effect? Oktay Arslan B; Demirhan E; Uçar Hoşgör ZZ J Voice; 2022 Jan; 36(1):119-122. PubMed ID: 32482493 [TBL] [Abstract][Full Text] [Related]
31. [Botulinum toxin. A new therapeutic alternative in spastic dysphonia (laryngeal abductor dystonia)]. Loven JO; Brøndbo K; Ganes T Tidsskr Nor Laegeforen; 1993 Mar; 113(7):841-3. PubMed ID: 8480289 [TBL] [Abstract][Full Text] [Related]
32. Life Threatening Delayed Complication of Botulinum Toxin Injection for Treatment of Spasmodic Dysphonia. Yershov D; Partridge R Prague Med Rep; 2020; 121(2):114-117. PubMed ID: 32553095 [TBL] [Abstract][Full Text] [Related]
33. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients. Blitzer A; Brin MF; Stewart CF Laryngoscope; 1998 Oct; 108(10):1435-41. PubMed ID: 9778279 [TBL] [Abstract][Full Text] [Related]
34. Adductor spasmodic dysphonia: Botulinum toxin a injections or laser thyroarytenoid myoneurectomy? A comparison from the patient perspective. Schuering JHC; Heijnen BJ; Sjögren EV; Langeveld APM Laryngoscope; 2020 Mar; 130(3):741-746. PubMed ID: 31169922 [TBL] [Abstract][Full Text] [Related]